Current and future perspectives in unresectable locally advanced esophageal squamous cell cancer (Review)

  • Authors:
    • Weijia Zhang
    • Min Zhu
    • Ying Xiang
    • Yujiao Sun
    • Shuang Li
    • Jun Cai
    • Hai Zeng
  • View Affiliations

  • Published online on: March 8, 2024     https://doi.org/10.3892/or.2024.8724
  • Article Number: 65
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Definitive concurrent chemoradiotherapy has been the main standard treatment method for unresectable locally advanced esophageal squamous cell cancer (ESCC) since 1999. However, several disadvantages continue to be associated with this type of treatment, including a high local failure rate (reaching ~50% within 3 years) and a median overall survival (OS) time of 16.9 months. In addition, the 5‑year overall survival rate of patients remains relatively low, at only ~21% for patients with ESCC with TNM stage T1‑3N0‑1M0. Burgeoning clinical trials and continually updating treatment modalities are currently in the process of being developed for the treatment of unresectable locally advanced ESCC. Compared with definitive concurrent chemoradiotherapy alone, clinical trials that have examined the efficacy of induction therapy, consolidation therapy, immunotherapy and targeted therapy have observed a prolonged median progression‑free survival and OS. Salvage surgery can also bring benefits to some patients. Therefore, the present review aimed to provide a comprehensive overview on the latest progress that is being made in the development of treatment strategies for unresectable locally advanced ESCC, taking into account the several new challenges that need to be overcome.
View References

Related Articles

Journal Cover

May-2024
Volume 51 Issue 5

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Zhang W, Zhu M, Xiang Y, Sun Y, Li S, Cai J and Zeng H: Current and future perspectives in unresectable locally advanced esophageal squamous cell cancer (Review). Oncol Rep 51: 65, 2024.
APA
Zhang, W., Zhu, M., Xiang, Y., Sun, Y., Li, S., Cai, J., & Zeng, H. (2024). Current and future perspectives in unresectable locally advanced esophageal squamous cell cancer (Review). Oncology Reports, 51, 65. https://doi.org/10.3892/or.2024.8724
MLA
Zhang, W., Zhu, M., Xiang, Y., Sun, Y., Li, S., Cai, J., Zeng, H."Current and future perspectives in unresectable locally advanced esophageal squamous cell cancer (Review)". Oncology Reports 51.5 (2024): 65.
Chicago
Zhang, W., Zhu, M., Xiang, Y., Sun, Y., Li, S., Cai, J., Zeng, H."Current and future perspectives in unresectable locally advanced esophageal squamous cell cancer (Review)". Oncology Reports 51, no. 5 (2024): 65. https://doi.org/10.3892/or.2024.8724